The U.S. Food and Drug Administration is looking to authorize the emergency use of Pfizer's vaccines for adolescents between the ages of 12 and 15 next week.
The New York Times reported the news, citing officials familiar with the agency's plans.
The U.S. FDA since last December has only been allowing the use of Pfizer's vaccines for those aged 16 and older.
But after conducting a trial of close to 23-hundred juveniles aged from 12 to 15, Pfizer have said they found that the vaccine is as safe and effective as it is for adults.
This could come as good news for parents who are looking to put their children back in school and summer camps.